Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Diabetologia|April 1, 1984
The effect of a new specific alpha-amylase inhibitor on post-prandial glucose and insulin excursions in normal subjects and Type 2 (non-insulin-dependent) diabetic patientsH G Eichler, A Korn, S Gasic, et al.Antimicrobial Agents and Chemotherapy|March 21, 2001
Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cellsC M Apfel, S Evers, C Hubschwerlen, et al.Antimicrobial Agents and Chemotherapy|March 21, 2001
Peptide deformylase as an antibacterial drug target: target validation and resistance developmentC M Apfel, H Locher, S Evers, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1992
A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effectsC Apfel, F Bauer, M Crettaz, et al.Journal of Medicinal Chemistry|June 1, 2001
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitorsC Apfel, D W Banner, D Bur, et al.Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.Pageof 1